Purpose; After cisplatin- and bleomycin-containing chemotherapy for testicular cancer, part of the patient population will develop acute or long-term cardiovascular toxicity. It is largely unknown whether standard tests can be used to assess chemotherapy-induced cardiovascular changes.Patients and Methods; In 65 testicular cancer patients (median age, 27 years; range, 18 to 48 years), we measured the following cardiovascular parameters before and within 10 weeks after completion of cisplatin-based chemotherapy: platelet numbers, plasma levels of hemostatic and fibrinolytic factors, 24-hour ambulatory blood pressure, baroreflex sensitivity, intima-media thickness of the common carotid artery, and flow-mediated vasodilation of the brachial ar...
Background: Metastatic testicular cancer (TC) can be cured with bleomycin, etoposide and cisplatin (...
Background: Late effects of cisplatin-based chemotherapy in testicular cancer survivors (TCS) includ...
Purpose: To determine whether long-term survivors of metastatic testicular cancer have an increased ...
Purpose; After cisplatin- and bleomycin-containing chemotherapy for testicular cancer, part of the p...
Background:After treatment with cisplatin-based chemotherapy for testicular cancer (TC), patients ha...
Long-term cardiovascular morbidity is increasingly observed in chemotherapy-treated testicular cance...
Background: Cross-sectional studies showed that treatment with cisplatin chemotherapy for testicular...
Background: Cisplatin-based chemotherapy increases the risk of cardiovascular and renal disease. ...
Testicular cancer patients have an increased risk for coronary artery disease more than ten years af...
Aims - Cisplatin-based chemotherapy (CBCT) is essential in the treatment of metastatic testicular ca...
Anne H Blaes,1 Daniel A Mulrooney,2 Rachel Isaksson Vogel,3 Anna Solovey,1 Robert Hebbel,1 Bruce A P...
Background: Metastatic testicular cancer (TC) can be cured with bleomycin, etoposide and cisplatin (...
Background: Late effects of cisplatin-based chemotherapy in testicular cancer survivors (TCS) includ...
Purpose: To determine whether long-term survivors of metastatic testicular cancer have an increased ...
Purpose; After cisplatin- and bleomycin-containing chemotherapy for testicular cancer, part of the p...
Background:After treatment with cisplatin-based chemotherapy for testicular cancer (TC), patients ha...
Long-term cardiovascular morbidity is increasingly observed in chemotherapy-treated testicular cance...
Background: Cross-sectional studies showed that treatment with cisplatin chemotherapy for testicular...
Background: Cisplatin-based chemotherapy increases the risk of cardiovascular and renal disease. ...
Testicular cancer patients have an increased risk for coronary artery disease more than ten years af...
Aims - Cisplatin-based chemotherapy (CBCT) is essential in the treatment of metastatic testicular ca...
Anne H Blaes,1 Daniel A Mulrooney,2 Rachel Isaksson Vogel,3 Anna Solovey,1 Robert Hebbel,1 Bruce A P...
Background: Metastatic testicular cancer (TC) can be cured with bleomycin, etoposide and cisplatin (...
Background: Late effects of cisplatin-based chemotherapy in testicular cancer survivors (TCS) includ...
Purpose: To determine whether long-term survivors of metastatic testicular cancer have an increased ...